Wearable eye-tracker aims to catch dizziness in the act

NCT ID NCT04026516

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests a wearable device called CAVA that records eye and head movements for 30 days in people with dizziness conditions like Meniere's disease and BPPV. The goal is to see if the device can accurately detect episodes of nystagmus, an eye movement linked to dizziness, and help identify when dizzy events occur. Participants wear the device almost all day, and researchers compare the device's findings with reported dizzy episodes to measure its accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CAVA device, a wearable that records eye and head movements continuously for 30 days
What this could lead to
If successful, this could lead to a reliable, home-based diagnostic tool for dizziness conditions, reducing the need for clinic visits.
What could go wrong
The trial is small and early-stage, and the device's accuracy in detecting nystagmus may not reach the target of 95%, or it may be uncomfortable for long-term wear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PAROXYSMAL POSITIONAL VERTIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Norfolk & Norwich University Hospitals NHS Foundation Trust

    Norwich, Norfolk, NR4 7UY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.